1. Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA [Internet]. 2020 Apr 28;323(16):1574-81. Available from: [
DOI:10.1001/jama.2020.5394] [
PMID] [
PMCID]
2. Lodder W, Maria A, Husman DR. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19 . The COVID-19 resource centre is hosted on Elsevier Connect , the company ' s public news and information . 2020;(January).
3. Molavi Z, Razi S, Mirmotalebisohi SA, Adibi A, Sameni M, Karami F, et al. Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach. Biomed Pharmacother. 2021;138. [
DOI:10.1016/j.biopha.2021.111544] [
PMID] [
PMCID]
4. Mohammad S, Hashemi A, Thijssen M, Younes S, Alijan H. Human gene polymorphisms and their possible impact on the clinical outcome of SARS ‑ CoV ‑ 2 infection. Arch Virol [Internet]. 2021;166(8):2089-108. Available from: [
DOI:10.1007/s00705-021-05070-6] [
PMID] [
PMCID]
5. WHO Coronavirus disease (COVID-19) dashboard [Internet]. [cited 2020 Jun 15]. Available from: https://covid19.who.int/
6. Center. JHCR. No TitleJohn Hopkins Coronavirus Resource Center. [Internet]. [cited 2020 Jun 15]. Available from: https://coronavirus.jhu.edu/map.html
7. Rokkas T. Gastrointestinal involvement in covid-19: A systematic review and meta-analysis. Ann Gastroenterol. 2020;33(4):355-65. [
DOI:10.20524/aog.2020.0506] [
PMID] [
PMCID]
8. Zhou Z, Zhao N, Shu Y, Han S, Chen B, Shu X. Effect of Gastrointestinal Symptoms in Patients With COVID-19. Gastroenterology. 2020;158(8):2294-7. [
DOI:10.1053/j.gastro.2020.03.020] [
PMID] [
PMCID]
9. Guan W, Liang W, He J, Zhong N. Cardiovascular comorbidity and its impact on patients with Covid-19. Eur Respir J. 2020;55(6). [
DOI:10.1183/13993003.01227-2020] [
PMID] [
PMCID]
10. Simonsick M, Ferrucci L, Resnick SM. Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission. Clin Infect Dis. 2020;10.
11. Dai M, Liu D, Liu M, Zhou F, Li G, Chen Z, et al. Patients with cancer appear more vulnerable to SARS-COV-2: a multicenter study during the COVID-19 outbreak. Cancer Discov. 2020;10(6):783-91.
https://doi.org/10.2139/ssrn.3558017 [
DOI:10.1158/2159-8290.CD-20-0422] [
PMID] [
PMCID]
12. Blanco JL, Ambrosioni J, Garcia F, Martínez E, Soriano A, Mallolas J, et al. COVID-19 in patients with HIV: clinical case series. Lancet HIV. 2020;7(5):e314-6. [
DOI:10.1016/S2352-3018(20)30111-9]
13. Hoffmann M, Mösbauer K, Hofmann-Winkler H, Kaul A, Kleine-Weber H, Krüger N, et al. Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2. Nature. 2020;585(7826):588-90. [
DOI:10.1038/s41586-020-2575-3] [
PMID]
14. Nobel YR, Phipps M, Zucker J, Lebwohl B, Wang TC, Sobieszczyk ME, et al. Gastrointestinal symptoms and coronavirus disease 2019: a case-control study from the United States. Gastroenterology. 2020;159(1):373-5. [
DOI:10.1053/j.gastro.2020.04.017] [
PMID] [
PMCID]
15. Arima Y, Kutsuna S, Shimada T, Suzuki M, Suzuki T, Kobayashi Y, et al. Ssevere acute respiratory syndrome coronavirus 2 infection among returnees to Japan from Wuhan, China, 2020. Emerg Infect Dis. 2020;26(7):1596. [
DOI:10.3201/eid2607.200994] [
PMID] [
PMCID]
16. Qureshi H. SHORT COMMUNICATION The digestive system and the COVID-19 S-99. 2020;(January):98-100. [
DOI:10.5455/JPMA.19] [
PMID]
17. Gu J, Han B, Wang J. COVID-19: gastrointestinal manifestations and potential fecal-oral transmission. Gastroenterology. 2020;158(6):1518-9. [
DOI:10.1053/j.gastro.2020.02.054] [
PMID] [
PMCID]
18. Zhang W, Du R-H, Li B, Zheng X-S, Yang X-L, Hu B, et al. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect. 2020;9(1):386-9. [
DOI:10.1080/22221751.2020.1729071] [
PMID] [
PMCID]
19. Cheng JL, Huang C, Zhang GJ, Liu DW, Li P, Lu CY, et al. Epidemiological characteristics of novel coronavirus pneumonia in Henan. Zhonghua jie he he hu xi za zhi= Zhonghua Jiehe he Huxi Zazhi= Chinese J Tuberc Respir Dis. 2020;43:E027-E027.
20. Yi Y, Lagniton PNP, Ye S, Li E, Xu R-H. COVID-19: what has been learned and to be learned about the novel coronavirus disease. Int J Biol Sci. 2020;16(10):1753. [
DOI:10.7150/ijbs.45134] [
PMID] [
PMCID]
21. Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis GJ van, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol A J Pathol Soc Gt Britain Irel. 2004;203(2):631-7. [
DOI:10.1002/path.1570] [
PMID] [
PMCID]
22. Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H. Evidence for Gastrointestinal Infection of SARS-CoV-2. Gastroenterology [Internet]. 2020 May 1;158(6):1831-1833.e3. Available from: [
DOI:10.1053/j.gastro.2020.02.055] [
PMID] [
PMCID]
23. Strickler JG, Singleton TP, Copenhaver CM, Erice A, Snover DC. Adenovirus in the gastrointestinal tracts of immunosuppressed patients. Am J Clin Pathol. 1992 Apr;97(4):555-8. [
DOI:10.1093/ajcp/97.4.555] [
PMID]
24. Ciarlet M, Estes MK. Rotavirus and calicivirus infections of the gastrointestinal tract. Curr Opin Gastroenterol. 2001 Jan;17(1):10-6. [
DOI:10.1097/00001574-200101000-00003] [
PMID]
25. Agholi M, Safaei A, Ramzi M, Hatam GR, Sarvari J. A survey of the frequency of cytomegalovirus-associated diarrhea in immunocompromised patients using a non-invasive method. 2018;10(2):143-50.
26. Cheung KS, Hung IFN, Chan PPY, Lung KC, Tso E, Liu R, et al. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from the Hong Kong cohort and systematic review and meta-analysis. Gastroenterology. 2020; [
DOI:10.1053/j.gastro.2020.03.065] [
PMID] [
PMCID]
27. Kotfis K, Skonieczna-Żydecka K. COVID-19: gastrointestinal symptoms and potential sources of SARS-CoV-2 transmission. Anaesthesiol Intensive Ther [Internet]. 2020;52(2):171-2. Available from: http://dx.doi.org/10.5114/ait.2020.93867 [
DOI:10.5114/ait.2020.93867] [
PMID]
28. Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh C-L, Abiona O, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science (80- ) [Internet]. 2020 Mar 13;367(6483):1260 LP - 1263. Available from: http://science.sciencemag.org/content/367/6483/1260.abstract [
DOI:10.1126/science.abb2507] [
PMID] [
PMCID]
29. Du M, Cai G, Chen F, Christiani DC, Zhang Z, Wang M. Multiomics Evaluation of Gastrointestinal and Other Clinical Characteristics of COVID-19. Gastroenterology. 2020 Jun;158(8):2298-2301.e7. [
DOI:10.1053/j.gastro.2020.03.045] [
PMID] [
PMCID]
30. Hashimoto T, Perlot T, Rehman A, Trichereau J, Ishiguro H, Paolino M, et al. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature. 2012;487(7408):477-81. [
DOI:10.1038/nature11228] [
PMID] [
PMCID]
31. Ye Q, Wang B, Zhang T, Xu J, Shang S. The mechanism and treatment of gastrointestinal symptoms in patients with COVID-19. Am J Physiol Liver Physiol [Internet]. 2020 Jul 8;319(2):G245-52. Available from: [
DOI:10.1152/ajpgi.00148.2020] [
PMID] [
PMCID]
32. He L, Ding Y, Zhang Q, Che X, He Y, Shen H, et al. Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS. J Pathol. 2006 Nov;210(3):288-97. [
DOI:10.1002/path.2067] [
PMID] [
PMCID]
33. Villapol S. Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome. Transl Res. 2020 Dec;226:57-69. [
DOI:10.1016/j.trsl.2020.08.004] [
PMID] [
PMCID]
34. Patel KP, Patel PA, Vunnam RR, Hewlett AT, Jain R, Jing R, et al. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19 . The COVID-19 resource centre is hosted on Elsevier Connect , the company ' s public news and information . J Clin Virol J. 2020;(January).
35. Lauer SA, Grantz KH. Qifang Bi, Forrest K Jones, Qulu Zheng, Hannah R Meredith, Andrew S Azman, Nicholas G Reich, and Justin Lessler. 2020."The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application." Ann Intern Med. 14. [
DOI:10.1101/2020.02.02.20020016]
36. Cha MH, Regueiro M, Sandhu DS. Gastrointestinal and hepatic manifestations of COVID-19: A comprehensive review. World J Gastroenterol. 2020;26(19):2323-32. [
DOI:10.3748/wjg.v26.i19.2323] [
PMID] [
PMCID]
37. Triki M, Charfi S, Bouzidi L, Makni S, Kallel R, Boudawara ETT. Pathological Features of the Novel Human Coronavirus Disease ( Covid-19 ) : a Review Aspects Anatomo-Pathologiques De L ' Infection Par Le Nouveau Coronavirus ( Covid-19 ) : Revue De La Litterature.
38. Hikmet F, Méar L, Edvinsson Å, Micke P, Uhlén M, Lindskog C. The protein expression profile of ACE2 in human tissues. Mol Syst Biol [Internet]. 2020 Jul;16(7):e9610-e9610. Available from: https://pubmed.ncbi.nlm.nih.gov/32715618 [
DOI:10.15252/msb.20209610] [
PMID] [
PMCID]
39. Tian Y, Rong L, Nian W, He Y. Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission. Aliment Pharmacol Ther. 2020;51(9):843-51. [
DOI:10.1111/apt.15731] [
PMID] [
PMCID]
40. Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020; [
DOI:10.1056/NEJMoa2001191] [
PMID] [
PMCID]
41. Redd WD, Zhou JC, Hathorn KE, McCarty TR, Bazarbashi AN, Thompson CC, et al. Prevalence and Characteristics of Gastrointestinal Symptoms in Patients With Ssevere acute respiratory Syndrome Coronavirus 2 Infection in the United States: A Multicenter Cohort Study. Gastroenterology [Internet]. 2020;159(2):765-767.e2. Available from: [
DOI:10.1053/j.gastro.2020.04.045] [
PMID] [
PMCID]
42. Lee SW, Ha EK, Yeniova AÖ, Moon SY, Kim SY, Koh HY, et al. Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching. Gut. 2020;gutjnl-2020-322248. [
DOI:10.1136/gutjnl-2020-322248] [
PMID]
43. Liu M, He P, Liu HG, Wang XJ, Li FJ, Chen S, et al. [Clinical characteristics of 30 medical workers infected with new coronavirus pneumonia]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese J Tuberc Respir Dis. 2020 Feb;43(0):E016.
44. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. [
DOI:10.1016/S0140-6736(20)30183-5]
45. Cholankeril G, Podboy A, Aivaliotis VI, Tarlow B, Pham EA, Spencer SP, et al. High Prevalence of Concurrent Gastrointestinal Manifestations in Patients With Ssevere acute respiratory Syndrome Coronavirus 2: Early Experience From California. Gastroenterology. 2020 Aug;159(2):775-7. [
DOI:10.1053/j.gastro.2020.04.008] [
PMID] [
PMCID]
46. Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt GM, et al. A major outbreak of ssevere acute respiratory syndrome in Hong Kong. N Engl J Med. 2003;348(20):1986-94. [
DOI:10.1056/NEJMoa030685] [
PMID]
47. Leung WK, To K, Chan PKS, Chan HLY, Wu AKL, Lee N, et al. Enteric involvement of ssevere acute respiratory syndrome-associated coronavirus infection. Gastroenterology. 2003;125(4):1011-7.
https://doi.org/10.1016/S0016-5085(03)01215-0 [
DOI:10.1016/j.gastro.2003.08.001]
48. Hung IFN, Cheng VCC, Wu AKL, Tang BSF, Chan KH, Chu CM, et al. Viral loads in clinical specimens and SARS manifestations. Emerg Infect Dis. 2004;10(9):1550. [
DOI:10.3201/eid1009.040058] [
PMID] [
PMCID]
49. Ling Y, Xu S-B, Lin Y-X, Tian D, Zhu Z-Q, Dai F-H, et al. Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients. Chin Med J (Engl). 2020; [
DOI:10.1097/CM9.0000000000000774] [
PMID] [
PMCID]
50. Tang A, Tong Z, Wang H, Dai Y, Li K, Liu J, et al. Early release-Detection of novel coronavirus By RT-PCR in stool specimen from asymptomatic child, China. 2020; [
DOI:10.3201/eid2606.20.0301]
51. Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med. 2020;382(12):1177-9. [
DOI:10.1056/NEJMc2001737] [
PMID] [
PMCID]
52. Peiris JSM, Chu C-M, Cheng VC-C, Chan KS, Hung IFN, Poon LLM, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003;361(9371):1767-72. [
DOI:10.1016/S0140-6736(03)13412-5]
53. Chan KH, Poon LLLM, Cheng VCC, Guan Y, Hung IFN, Kong J, et al. Detection of SARS coronavirus in patients with suspected SARS. Emerg Infect Dis. 2004;10(2):294. [
DOI:10.3201/eid1002.030610] [
PMID] [
PMCID]
54. Xiao YQ, Liu Y, Zheng SL, Yang Y, Fan S, Yang C, et al. Relationship between hypertension and body mass index, waist circumference and waist-hip ratio in middle-aged and elderly residents. Zhonghua liu xing bing xue za zhi= Zhonghua liuxingbingxue zazhi. 2016;37(9):1223-7.
55. Sarvari J, Mojtahedi Z, Kuramitsu Y, Fattahi MR. Comparative Proteomics of Sera From HCC Patients With Different Origins. 2014;14(1):1-6. [
DOI:10.5812/hepatmon.13103] [
PMID] [
PMCID]
56. David S, Hamilton JP. Drug-induced Liver Injury. US Gastroenterol Hepatol Rev [Internet]. 2010 Jan 1;6:73-80. Available from: https://pubmed.ncbi.nlm.nih.gov/21874146
57. Weber J, Gunn H, Yang J, Parkinson D, Topalian S, Schwartzentruber D, et al. A Phase I Trial of Intravenous Interleukin-6 in Patients with Advanced Cancer. J Immunother [Internet]. 1994;15(4). Available from: https://journals.lww.com/immunotherapy-journal/Fulltext/1994/05000/A_Phase_I_Trial_of_Intravenous_Interleukin_6_in.8.aspx [
DOI:10.1097/00002371-199405000-00008] [
PMID]
58. Banks RE, Forbes MA, Patel PM, Storr M, Hallam S, Clarke D, et al. SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT GLYCOSYLATED INTERLEUKIN 6 IN PATIENTS WITH CANCER: PHARMACOKINETICS, PHARMACODYNAMICS AND IMMUNOMODULATORY EFFECTS. Cytokine [Internet]. 2000;12(4):388-96. Available from: https://www.sciencedirect.com/science/article/pii/S1043466699905562 [
DOI:10.1006/cyto.1999.0556] [
PMID]
59. Gauldie J, Richards C, Harnish D, Lansdorp P, Baumann H. Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci [Internet]. 1987 Oct 1;84(20):7251 LP - 7255. Available from: http://www.pnas.org/content/84/20/7251.abstract [
DOI:10.1073/pnas.84.20.7251] [
PMID] [
PMCID]
60. Effenberger M, Grander C, Grabherr F, Griesmacher A, Ploner T, Hartig F, et al. Systemic inflammation as fuel for acute liver injury in COVID-19. Dig Liver Dis [Internet]. 2021 Feb 1;53(2):158-65. Available from: [
DOI:10.1016/j.dld.2020.08.004] [
PMID] [
PMCID]
61. Fan Z, Chen L, Li J, Tian C, Zhang Y, Huang S, et al. Clinical Features of COVID-19-Related Liver Damage. medRxiv [Internet]. 2020 Jan 1;2020.02.26.20026971. Available from: http://medrxiv.org/content/early/2020/02/28/2020.02.26.20026971.abstract
62. Zhang C, Shi L, Wang F-S. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol [Internet]. 2020 May 1;5(5):428-30. Available from: [
DOI:10.1016/S2468-1253(20)30057-1]
63. Guo Y-R, Cao Q-D, Hong Z-S, Tan Y-Y, Chen S-D, Jin H-J, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020 Mar;7(1):11. [
DOI:10.1186/s40779-020-00240-0] [
PMID] [
PMCID]
64. Wong SH, Lui RNS, Sung JJY. Covid-19 and the digestive system. J Gastroenterol Hepatol [Internet]. 2020 May 1;35(5):744-8. Available from: [
DOI:10.1111/jgh.15047] [
PMID]
65. Chai X, Hu L, Zhang Y, Han W, Lu Z, Ke A, et al. Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV Infection. bioRxiv [Internet]. 2020 Jan 1;2020.02.03.931766. Available from: http://biorxiv.org/content/early/2020/02/04/2020.02.03.931766.abstract
66. Yao XH, Li TY, He ZC, Ping YF, Liu HW, Yu SC, et al. [A pathological report of three COVID-19 cases by minimal invasive autopsies]. Zhonghua bing li xue za zhi = Chinese J Pathol. 2020 May;49(5):411-7.
67. Zhang Y, Zheng L, Liu L, Zhao M, Xiao J, Zhao Q. Liver impairment in COVID-19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city, China. Liver Int Off J Int Assoc Study Liver. 2020 Sep;40(9):2095-103. [
DOI:10.1111/liv.14455] [
PMID]
68. Bangash MN, Patel J, Parekh D. COVID-19 and the liver: little cause for concern. Vol. 5, The lancet. Gastroenterology & hepatology. 2020. p. 529-30. [
DOI:10.1016/S2468-1253(20)30084-4]
69. Wander P, Epstein M, Bernstein D. COVID-19 Presenting as Acute Hepatitis. Am J Gastroenterol. 2020 Jun;115(6):941-2. [
DOI:10.14309/ajg.0000000000000660] [
PMID] [
PMCID]
70. Chornenkyy Y, Mejia-Bautista M, Brucal M, Blanke T, Dittmann D, Yeldandi A, et al. Liver Pathology and SARS-CoV-2 Detection in Formalin-Fixed Tissue of Patients with COVID-19. Am J Clin Pathol. 2021;155(6):802-14. [
DOI:10.1093/ajcp/aqab009] [
PMID] [
PMCID]
71. Mao R, Liang J, Shen J, Ghosh S, Zhu L-R, Yang H, et al. Implications of COVID-19 for patients with pre-existing digestive diseases. lancet Gastroenterol Hepatol. 2020 May;5(5):425-7. [
DOI:10.1016/S2468-1253(20)30076-5]
72. Indahningrum R putri. Covariance structure analysis of health-related indicators in the elderly at home with a focus on subjective health. 2020;2507(1):1-9.
73. Pan L, Mu M, Yang P, Sun Y, Wang R, Yan J, et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am J Gastroenterol. 2020;115. [
DOI:10.14309/ajg.0000000000000620] [
PMID] [
PMCID]
74. Xu L, Su K-D, Wei X-C, Zhang J, Li H-R. Chemical Constituents of Kadsura coccinea. Chem Nat Compd [Internet]. 2018;54(2):242-4. Available from: [
DOI:10.1007/s10600-018-2313-3]
75. Xu L, Ying S, Hu J, Wang Y, Yang M, Ge T, et al. Pneumonia in patients with cirrhosis: risk factors associated with mortality and predictive value of prognostic models. Respir Res [Internet]. 2018 Dec 4;19(1):242. Available from: https://pubmed.ncbi.nlm.nih.gov/30514312 [
DOI:10.1186/s12931-018-0934-5] [
PMID] [
PMCID]
76. Albillos A, Lario M, Álvarez-Mon M. Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance. J Hepatol. 2014 Dec;61(6):1385-96. [
DOI:10.1016/j.jhep.2014.08.010] [
PMID]
77. Yang L, Han Y, Nilsson-Payant BE, Gupta V, Wang P, Duan X, et al. A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids. Cell Stem Cell [Internet]. 2020 Jul 2;27(1):125-136.e7. Available from: [
DOI:10.1016/j.stem.2020.06.015] [
PMID] [
PMCID]
78. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet [Internet]. 2020 Feb 15;395(10223):507-13. Available from: [
DOI:10.1016/S0140-6736(20)30211-7]
79. Liu F, Long X, Zhang B, Zhang W, Chen X, Zhang Z. ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2020 Aug;18(9):2128-2130.e2. [
DOI:10.1016/j.cgh.2020.04.040] [
PMID] [
PMCID]
80. Liu F, Long X, Zhang B, Zhang W, Chen X, Zhang Z. ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection. Clin Gastroenterol Hepatol. 2020;18(9):2128-2130.e2. [
DOI:10.1016/j.cgh.2020.04.040] [
PMID] [
PMCID]
81. Wang F, Wang H, Fan J, Zhang Y, Wang H, Zhao Q. Pancreatic Injury Patterns in Patients With Coronavirus Disease 19 Pneumonia. Gastroenterology [Internet]. 2020 Jul 1;159(1):367-70. Available from: [
DOI:10.1053/j.gastro.2020.03.055] [
PMID] [
PMCID]
82. Tsibouris P, Ekmektzoglou K, Agorogianni A, Kalantzis C, Theofanopoulou A, Toumbelis K, et al. Gastrointestinal involvement in covid-19 patients: A retrospective study from a greek covid-19 referral hospital. Ann Gastroenterol. 2020;33(5):465-465. [
DOI:10.20524/aog.2020.0514] [
PMID] [
PMCID]
83. BURUK K, OZLU T. New Coronavirus: SARS-COV-2. Mucosa. 2020;(March 2020):1-4. [
DOI:10.33204/mucosa.706906]
84. Jiehao C, Jin X, Daojiong L, Zhi Y, Lei X, Zhenghai Q, et al. A Case Series of Children With 2019 Novel Coronavirus Infection: Clinical and Epidemiological Features. Clin Infect Dis an Off Publ Infect Dis Soc Am. 2020 Sep;71(6):1547-51. [
DOI:10.1093/cid/ciaa198] [
PMID] [
PMCID]
85. Ianiro G, Mullish BH, Kelly CR, Sokol H, Kassam Z, Ng SC, et al. Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel. lancet Gastroenterol Hepatol. 2020 May;5(5):430-2. [
DOI:10.1016/S2468-1253(20)30082-0]
86. Zhang J, Wang S, Xue Y. Fecal specimen diagnosis 2019 novel coronavirus-infected pneumonia. J Med Virol. 2020 Jun;92(6):680-2. [
DOI:10.1002/jmv.25742] [
PMID] [
PMCID]